BridgeBio Pharma (BBIO) Q2 2024 Earnings

2MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-1.08
-0.79
-0.49
-0.2

Details

Expected EPS
-0.736761
Actual EPS
-0.2
Surprise EPS
0.54
Surprise Percent
+72.85%

Description

BridgeBio Pharma (BBIO) has reported earnings of -0.2 per share for Q2 2024.

0 Comments

Share your thoughts